Quercetin: Anti-Inflammatory Evidence, Zinc & the Real Picture
Reviewed by a UK-registered pharmacist
All Medibro health content is reviewed for accuracy and MHRA compliance before publication.
What Is Quercetin?
Quercetin is a flavonoid β a class of polyphenolic plant pigments found widely in the plant kingdom. It is one of the most abundant flavonoids in the human diet, found in significant amounts in:
- Onions (particularly red onions): up to 50mg per 100g - Apples (especially the skin): 2β10mg per 100g - Capers: the highest dietary source at up to 234mg per 100g (rarely eaten in large quantities) - Kale, broccoli, and other Brassicas - Berries (blueberries, cranberries) - Green tea - Buckwheat
Despite being "in your diet," the amounts from typical UK food consumption are modest β estimated average intake is 10β30mg/day. Therapeutic doses used in clinical research range from 500β1,000mg/day, meaning supplementation is necessary to achieve potentially meaningful blood levels.
---
The Zinc Ionophore Mechanism and COVID Context
This is worth addressing directly because it drove enormous interest in quercetin from 2020 onwards.
What a zinc ionophore does: An ionophore is a molecule that facilitates the transport of ions across cell membranes. Zinc has intracellular antiviral activity (inhibiting viral RNA polymerase). However, zinc cannot enter cells freely β it requires a transporter. A zinc ionophore essentially "carries" zinc across the cell membrane, potentially increasing intracellular zinc availability.
The evidence base: In vitro studies (cell culture) showed quercetin can facilitate zinc entry into cells and inhibit SARS-CoV-2 replication in lab conditions. This theoretical mechanism was extrapolated by several researchers and widely disseminated online as a potential COVID preventive.
The reality: The leap from in vitro zinc ionophore activity to clinical COVID-19 prevention is not supported by reliable human trial data. A 2021 preprint RCT found no significant benefit of quercetin + zinc on COVID outcomes. The ionophore mechanism, while biochemically plausible in a test tube, faces the fundamental problem of quercetin's very poor oral bioavailability β the plasma concentrations achievable from supplementation may not reach the threshold required for meaningful ionophore activity in human tissue.
Quercetin remains interesting for its other, better-evidenced mechanisms. The zinc ionophore angle should not be the primary reason to take it.
---
The Bioavailability Problem
This is central to understanding quercetin supplementation. Quercetin from food sources and standard supplements has oral bioavailability of approximately 2β7% in most human pharmacokinetic studies β one of the poorest of any widely studied flavonoid.
The reasons: - Poor solubility in gut fluid (quercetin aglycone is hydrophobic) - Rapid intestinal metabolism and conjugation - Extensive first-pass metabolism in the liver
The form matters significantly. Quercetin in food exists primarily as glycosides (attached to sugar molecules) β quercetin-3-glucoside in onions, for example β which are actually better absorbed than the pure aglycone used in most supplements. Quercetin glucosides are absorbed in the small intestine via glucose transporters; pure quercetin aglycone relies on passive diffusion and is more extensively metabolised.
Forms with improved bioavailability:
- Quercetin dihydrate: The standard supplemental form; modestly better stability than anhydrous quercetin but similar bioavailability - Quercetin phytosome (Quercefit): Quercetin complexed with sunflower phospholipids. Pharmacokinetic studies show 20-fold greater plasma quercetin concentration compared to quercetin dihydrate at equivalent doses - Quercetin LipoMicel Matrix (Quercetin with MCT): Lipid-based delivery showing 10-fold improved absorption in some studies
Bromelain combination: Bromelain (a proteolytic enzyme from pineapple) is frequently combined with quercetin and claimed to improve absorption. The evidence for bromelain specifically enhancing quercetin absorption is limited; however, bromelain has its own anti-inflammatory activity and may contribute to synergistic anti-inflammatory effects.
---
Evidence: Anti-Inflammatory and Antioxidant Effects
Mast Cell Inhibition and Allergy
Quercetin is one of the most studied natural mast cell stabilisers. Mast cells release histamine, prostaglandins, and leukotrienes when activated by allergen-IgE complexes. Quercetin inhibits both IgE-dependent and IgE-independent mast cell degranulation in vitro and in animal models.
In human allergy research: - A 2016 double-blind trial found quercetin (100mg twice daily) significantly reduced symptom severity in Japanese cedar pollinosis (hay fever) over a 8-week pollen season compared to placebo - A 2012 trial found quercetin supplementation reduced pro-inflammatory cytokines (TNF-Ξ±, IL-6) in adults with metabolic syndrome after 8 weeks
The antiallergic evidence is modest but biologically plausible and consistent with the known mechanism.
NF-kB and Inflammatory Pathways
Like curcumin and black seed oil, quercetin inhibits NF-kB transcription, reducing downstream production of IL-1Ξ², IL-6, TNF-Ξ±, and COX-2-derived prostaglandins. It also inhibits 5-lipoxygenase (5-LOX), the enzyme that converts arachidonic acid to pro-inflammatory leukotrienes β the same pathway targeted by montelukast in asthma management.
A 2019 systematic review in Food & Function found quercetin supplementation significantly reduced CRP across 9 RCTs, with the strongest effects in populations with elevated baseline CRP (existing inflammation).
---
Cardiovascular Evidence
Blood Pressure
A 2016 meta-analysis in the Journal of Nutrition pooled data from 7 RCTs (587 participants) and found quercetin supplementation significantly reduced systolic blood pressure (mean -3.04 mmHg) and diastolic blood pressure (-2.63 mmHg) compared to placebo. Effects were more pronounced in doses β₯500mg/day and in hypertensive individuals.
The mechanism likely involves quercetin's capacity to inhibit angiotensin-converting enzyme (ACE) and to increase nitric oxide bioavailability in vascular endothelium.
LDL Cholesterol and Endothelial Function
Several trials have found modest reductions in LDL oxidation and improvements in endothelial function with quercetin supplementation. LDL oxidation is a key step in atherosclerotic plaque formation, making this a potentially important anti-cardiovascular effect. However, total and LDL cholesterol levels are not consistently reduced β quercetin's cardiovascular benefit appears more about reducing LDL oxidation than reducing LDL concentrations.
---
Senolytic Properties
An emerging and scientifically interesting application: a 2019 small clinical trial by Hickson et al. in EBioMedicine found that a combination of quercetin (1,000mg) and dasatinib (a chemotherapy drug) administered intermittently cleared senescent cells (dysfunctional "zombie" cells that accumulate with aging and drive inflammaging) from adipose tissue in humans. This was the first human senolytic trial.
This is early-phase research and the combination used a pharmaceutical drug alongside quercetin. However, it confirms that quercetin has genuine senolytic activity in humans β an area of significant anti-ageing research interest. Quercetin alone (without dasatinib) has shown senolytic activity in animal models but human data for quercetin monotherapy as a senolytic is limited.
---
Dosing Guide
- Anti-inflammatory / cardiovascular: 500β1,000mg/day of quercetin dihydrate, or 250β500mg/day of phytosome form - Allergy support: 250β500mg twice daily, beginning 4β6 weeks before allergy season - Timing: With meals containing fat for better absorption (especially relevant for standard quercetin dihydrate) - Bromelain: Often combined at 250β500mg/day β the combination is widely available in UK health shops
---
Quercetin's Place in a Supplement Protocol
Quercetin is best viewed as a useful adjunct with a reasonable evidence base rather than a primary or standalone intervention. It is most relevant for:
- People with chronic low-grade inflammation who want a plant-based anti-inflammatory - Seasonal allergy sufferers looking for a natural mast cell stabiliser alongside or instead of antihistamines - Those with mildly elevated blood pressure in conjunction with dietary changes - Vegans and plant-based eaters building an antioxidant-rich supplement stack
The COVID-era hype positioned quercetin as something it is not. Strip that away and you have a well-tolerated, modestly effective polyphenol with genuine anti-inflammatory, antiallergic, and cardiovascular benefits β most pronounced when using a bioavailable form at adequate doses. For a supplement available at Β£15β25/month, that is a reasonable value proposition.
---
Safety
Quercetin is extremely well-tolerated. At doses up to 1,000mg/day for up to 12 weeks (the longest trial durations), no serious adverse events have been reported. Mild GI discomfort is the most common side effect.
Interactions to be aware of: - Quinolone antibiotics (ciprofloxacin, levofloxacin): Quercetin inhibits P-glycoprotein and can increase plasma levels of these antibiotics β separate doses by at least 2 hours - Cyclosporine and other CYP3A4 substrates: Quercetin is a moderate CYP3A4 inhibitor at high doses; discuss with your prescriber if on immunosuppressants or transplant medications - Thyroid medication: Some in vitro evidence suggests quercetin may affect thyroid hormone metabolism; clinical significance is unclear but those on levothyroxine should mention quercetin to their GP
For the vast majority of healthy UK adults, quercetin supplementation at 500β1,000mg/day is safe for prolonged use.
β¨ Not sure which supplements are right for you?
Our 60-second quiz recommends a personalised stack based on your goals, diet and lifestyle. 8,400+ people found their stack this month β no email required.
Get weekly supplement insights
Join 12,000+ health-conscious readers. Plain-English science, no fluff, unsubscribe any time.
No spam. Unsubscribe any time.